Last reviewed · How we verify
NCT04561531
Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia.
NA trial testing 3%NaCl in Hyponatremia in 40 participants. Status unknown.
30 September 2021
Quick facts
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 30 September 2020 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- 3%NaCl
Conditions studied
- Hyponatremia — all drugs for Hyponatremia →
- Osmotic Demyelination Syndrome — all drugs for Osmotic Demyelination Syndrome →
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Who can join
18 and older, any sex, with Hyponatremia or Osmotic Demyelination Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare between intermittent bolus and traditional continuous drip of 3%NaCl in patients with severe symptomatic hyponatremia in Rajavithi Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04561531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyponatremia
Currently open trials in the same condition.
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
- NCT06020495 — Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia · Phase 3 · recruiting
- NCT06781710 — Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Synd · recruiting
- NCT07430787 — Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care · active not recruiting
- NCT06408077 — Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges · NA · recruiting
Other Department of Medical Services Ministry of Public Health of Thailand trials
Trials by the same sponsor.
- NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
- NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
- NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
- NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
- NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04561531 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
- Last refreshed: 25 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04561531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing